-
-
-
-
-
-
-
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences
-
-
-
-
-
-
-
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
-
-
-
-
-
-
-
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
-
-
-
-
-
-
-
Akoya Biosciences Appoints Pascal Bamford, PhD, as SVP, R&D and Laboratory Operations
-
-
-
-
-
-
-
Akoya and ZEISS to Co-Market Innovative CODEX® Spatial Biology Workflow
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

